ClinicalTrials.gg
Not yet recruitingNCT07832526MARCHUpdated Sep 22, 2026

Menstruation and Anemia Research: A Community Health Study

An interventional study of Standard of Care and Informational Series and follow-up support in Anemia, sponsored by University of Michigan. Not yet recruiting at 2 sites in United States. Open to female participants aged 21 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-09-22.

Sponsored by University of Michigan · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
180
Allocation
Randomized
Ages
21 Years to 55 Years
Sex
Female
01

Study summary

This research is studying if a community-based, community health worker (CHW) led psychosocial intervention improves hemoglobin levels among Black/African American and/or Hispanic or Latino women with anemia compared to standard of care.

The intervention group will demonstrate a greater mean increase in hemoglobin at follow up than the control group. The expected treatment difference effect is a between group difference of 1.0-point or greater in mean Hgb at follow up.

02

Conditions studied

  • Anemia

Keywords

  • Psychosocial intervention
  • Surveys
  • Iron deficiency anemia
  • Hemoglobin
  • Menstrual health
  • Abnormal uterine bleeding (AUB)
  • Community Health Worker
  • Community Based Participatory Research (CBPR)
  • Health Education
03

In context

Anemia

1,810 studies on the registry are indexed under Anemia; 215 are open to participants now.

This study's planned enrollment of 180 is above the median of 117 across 1,336 interventional studies indexed under Anemia.

Browse Anemia studies →

Lead sponsor

University of Michigan is the lead sponsor of 1,506 studies on the registry; 192 are open to participants now.

Of its 169 completed or terminated interventional studies of FDA-regulated products, 133 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 55 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Self-identify as black/African American and/or Hispanic/Latino
  2. Has had a menstrual period in the last 6 months
  3. (Hgb) by point of care (POC) test is less than 12.0 g/dL and greater than or equal to 7.0 g/dL
  4. Able to read, write, and communicate in Spanish and/or English

Exclusion criteria

Exclusion Criteria:

  1. Received iron infusion in the past month
  2. Recent (within the last 4 weeks) or anticipated major surgery with anesthesia for greater than 30 minutes within the next 3 months
  3. Undergone Bariatric (i.e. weight-loss) Surgery including Gastric Bypass Surgery, Gastric Sleeve Surgery or other Bariatric Surgery
  4. Diagnosed with anemia related to a condition other than iron deficiency, such as thalassemia or sickle cell disease or are a carrier.
  5. Diagnosed with cancer (not including thyroid, cervical, or non-melanoma skin cancer)
  6. Currently or within the last 3 months experiencing bloody or black tarry stools
  7. Currently or within the last 3 months vomiting blood or emesis that resembles dark coffee grounds
  8. Currently pregnant women
  9. by POC test is less than 7.0 g/dL
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Hemoglobin (Hb)

The protein in red blood cells that carries oxygen. A low level is anaemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
180 participants (estimated)

Study arms

  • Other
    Group 1-Standard of Care (SOC)

    Participants will be notified that they are anemic and receive written/verbal information on anemia and instructed to follow up with their healthcare provider (standard care)

    Behavioral: Standard of Care

  • Other
    Group 2-SOC and Education/CHW input

    Standard care and attend a community-based series of group-based information sessions and receive support from CHW to follow up with healthcare providers about their anemia

    Behavioral: Standard of Care · Behavioral: Informational Series and follow-up support

Interventions

  • BehavioralStandard of Care

    Participant will be given verbal and written information on taking iron.

  • BehavioralInformational Series and follow-up support

    The CHW-led intervention is a structured, community-based psychosocial education series for participants randomized to the intervention arm. Trained CHWs will deliver five sessions over 10 weeks covering: (1) blood and hemoglobin basics; (2) anemia and common treatments; (3) normal menstrual health; (4) abnormal uterine bleeding (AUB), including common causes and treatments; and (5) AUB across the reproductive lifespan, with review. Sessions may be in person or use another approved, accessible modality. Standardized materials and guides will support consistency while allowing questions, discussion, and culturally responsive dialogue. CHWs will help participants understand hemoglobin results, prepare questions, connect with providers or establish care, and navigate anemia-related follow-up. CHWs will not give medical advice, diagnose conditions, or prescribe treatment.

06

What researchers measure

Primary outcomes

  1. Hemoglobin levels (group level change)

    Blood samples will be obtained to measure hemoglobin levels

    Time frame: Visit 1 (approximately day 1), Visit 7 (approximately day 112)

Secondary outcomes

  1. Hemoglobin (Hgb) values (individual change)

    Blood samples will be obtained to measure hemoglobin levels

    Time frame: Visit 1 (approximately day 1), Visit 7 (approximately day 112)

  2. Self-reported hemoglobin levels

    Self reported hemoglobin value

    Time frame: Visit 1 (approximately day 1), Visit 7 (approximately day 112)

  3. Anemia status awareness

    Number of participants who answered correctly, "Is your hemoglobin value normal (i.e. not anemic)?

    Time frame: Visit 1 (approximately day 1), Visit 7 (approximately day 112)

  4. Knowledge of anemia

    Anemia knowledge is measured using a 20-item anemia knowledge assessment. Scores range from 0-20 and higher scores indicate greater anemia knowledge.

    Time frame: Visit 1 (approximately day 1), Visit 7 (approximately day 112)

  5. Confidence in managing anemia as measured by the Perceived Competence Scale

    Perceived Competence Scale is a 4-item questionnaire and assesses participants feelings of competence engaging in a behavior. It is calculated by averaging a person's score of the 4 items. Higher scores indicate greater levels of perceived capability in the relevant domain.

    Time frame: Visit 1 (approximately day 1), Visit 7 (approximately day 112)

  6. Knowledge of Abnormal uterine bleeding (AUB)/menstrual health based on knowledge assessment

    10-item menstrual health knowledge assessment. Scores range from 0-20 and higher scores indicate greater anemia knowledge. Scores range from 0-10 and higher scores indicate greater menstrual health knowledge.

    Time frame: Visit 1 (approximately day 1), Visit 7 (approximately day 112)

07

Study locations

2 sites
  • University of Michigan
    Ann Arbor, Michigan 48109, United States
    • Arthi Ramakrishnan, MS · ContactMARCH-Study@med.umich.edu · 734-615-8068
    • Erica Marsh, MD, MSCI, FACOG · Principal investigator
  • Community Health and Social Service Centers (CHASS)
    Detroit, Michigan 48209, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07832526
Responsible party
Erica Marsh (Professor of Reproductive Medicine and Obstetrics and Gynecology, University of Michigan) — Principal investigator
First posted
Sep 22, 2026
Start date
Sep 2026 (estimated)
Primary completion
Apr 2028 (estimated)
Completion
Apr 2028 (estimated)
Last update
Sep 22, 2026

Study contacts

Kirsten Trzeciak
Contact
kioard@med.umich.edu
734-647-0307
Arthi Ramakrishnan, MS
Contact
MARCH-Study@med.umich.edu
734-615-8068
Erica Marsh, MD, MSCI
principal investigator · University of Michigan

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion